Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF (1992). "The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules". J. Immunol.149 (9): 2841–50. PMID1383329.
Scheuermann, R. H.; Racila, E. (1995). "CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy". Leukemia and Lymphoma 18 (5): 385–397. doi:10.3109/10428199509059636. PMID 8528044.
Chung, E. Y.; Psathas, J. N.; Yu, D.; Li, Y.; Weiss, M. J.; Thomas-Tikhonenko, A. (2012). "CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis". Journal of Clinical Investigation 122 (6): 2257–2266. doi:10.1172/JCI45851. PMC 3366393. PMID 22546857. //www.ncbi.nlm.nih.gov/pmc/articles/PMC3366393/.
Fujimoto, M.; Sato, S. (2007). "B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity". Journal of Dermatological Science 46 (1): 1–9. doi:10.1016/j.jdermsci.2006.12.004. PMID 17223015.